Gen-Probe's Q1 Revenues up 7 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Gen-Probe today said that revenues for the first quarter rose 7 percent year over year as blood-screening revenues increased 12 percent.

The San Diego-based molecular diagnostics firm also announced a deal to be acquired by Hologic for $82.75 per share in cash for a total deal value of $3.7 billion.

Gen-Probe's revenues totaled $153.4 million, up from $143 million a year ago, and beating Wall Street estimates of $150.1 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.